These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 21809256

  • 1. [Treatment of parkinsonism and legal capacity].
    Wallesch CW.
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):441. PubMed ID: 21809256
    [No Abstract] [Full Text] [Related]

  • 2. Hypersexuality due to dopaminergic drugs.
    Prescrire Int; 2005 Dec; 14(80):224. PubMed ID: 16400746
    [Abstract] [Full Text] [Related]

  • 3. A case of hedonistic homeostatic dysregulation.
    Kessel BL.
    Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
    [Abstract] [Full Text] [Related]

  • 4. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E.
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [Abstract] [Full Text] [Related]

  • 5. [Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
    Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P.
    Rev Neurol (Paris); 2010 Oct; 166(10):816-21. PubMed ID: 20739041
    [Abstract] [Full Text] [Related]

  • 6. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    Wenzelburger R.
    Clin Neurophysiol; 2005 Sep; 116(9):1997-8. PubMed ID: 16055380
    [No Abstract] [Full Text] [Related]

  • 7. Pathological gambling in Parkinson's disease.
    Stocchi F.
    Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
    [No Abstract] [Full Text] [Related]

  • 8. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL, Schmitt L, Bagheri H.
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A, Kandimala G, Dewey RB, O'Suilleabhain P.
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [Abstract] [Full Text] [Related]

  • 10. Is pathological gambling in Parkinson's disease reduced by amantadine?
    Lee JY, Kim HJ, Jeon BS.
    Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
    [No Abstract] [Full Text] [Related]

  • 11. Medication-related impulse control and repetitive behaviors in Parkinson disease.
    Voon V, Fox SH.
    Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
    [Abstract] [Full Text] [Related]

  • 12. Dopamine is not dopamine.
    Soyka M.
    Addiction; 2012 Feb; 107(2):248. PubMed ID: 22248131
    [No Abstract] [Full Text] [Related]

  • 13. [Neuroleptic malignant syndrome-like state in eight patients with parkinsonism].
    Fujitake J, Kuno S, Nishitani H.
    Rinsho Shinkeigaku; 1984 Apr; 24(4):371-8. PubMed ID: 6744760
    [No Abstract] [Full Text] [Related]

  • 14. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract] [Full Text] [Related]

  • 15. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ.
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract] [Full Text] [Related]

  • 16. [Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].
    Miranda M, Slachevsky A, Bustamante L, Pérez C.
    Rev Med Chil; 2010 Apr; 138(4):521-2. PubMed ID: 20668805
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction.
    Brown RM, Lawrence AJ.
    Addiction; 2012 Feb; 107(2):250-1. PubMed ID: 22248133
    [No Abstract] [Full Text] [Related]

  • 19. [Parkinson's disease].
    Yokochi M.
    Ryoikibetsu Shokogun Shirizu; 1999 Feb; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract] [Full Text] [Related]

  • 20. Rehabilitation goals and strategies in Parkinson's disease.
    Ceravolo MG.
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):205-8. PubMed ID: 19532108
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.